Levetiracetam and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and epilepsy: a reasonable combination

Eur Heart J. 2019 Dec 7;40(46):3800-3801. doi: 10.1093/eurheartj/ehz657.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants
  • Atrial Fibrillation*
  • Epilepsy*
  • Humans
  • Levetiracetam
  • Warfarin

Substances

  • Anticoagulants
  • Levetiracetam
  • Warfarin